281 related articles for article (PubMed ID: 20678586)
1. Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.
Ohtaki N; Takahashi H; Kaneko K; Gomi Y; Ishikawa T; Higashi Y; Kurata T; Sata T; Kojima A
Vaccine; 2010 Sep; 28(40):6588-96. PubMed ID: 20678586
[TBL] [Abstract][Full Text] [Related]
2. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S
Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075
[TBL] [Abstract][Full Text] [Related]
3. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
[TBL] [Abstract][Full Text] [Related]
4. Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.
Magnusson SE; Karlsson KH; Reimer JM; Corbach-Söhle S; Patel S; Richner JM; Nowotny N; Barzon L; Bengtsson KL; Ulbert S; Diamond MS; Stertman L
Vaccine; 2014 Feb; 32(7):800-8. PubMed ID: 24380682
[TBL] [Abstract][Full Text] [Related]
5. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
[TBL] [Abstract][Full Text] [Related]
6. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.
Throsby M; Ter Meulen J; Geuijen C; Goudsmit J; de Kruif J
Expert Rev Vaccines; 2007 Apr; 6(2):183-91. PubMed ID: 17408368
[TBL] [Abstract][Full Text] [Related]
7. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
Garg H; Sedano M; Plata G; Punke EB; Joshi A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
[TBL] [Abstract][Full Text] [Related]
8. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine.
Lim CK; Takasaki T; Kotaki A; Kurane I
Virology; 2008 Apr; 374(1):60-70. PubMed ID: 18221765
[TBL] [Abstract][Full Text] [Related]
9. Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease.
Alonso-Padilla J; de Oya NJ; Blázquez AB; Escribano-Romero E; Escribano JM; Saiz JC
Vaccine; 2011 Feb; 29(9):1830-5. PubMed ID: 21211580
[TBL] [Abstract][Full Text] [Related]
10. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
[TBL] [Abstract][Full Text] [Related]
11. Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.
Li C; Liu F; Liang M; Zhang Q; Wang X; Wang T; Li J; Li D
Vaccine; 2010 Jun; 28(26):4294-300. PubMed ID: 20433802
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.
Volz A; Lim S; Kaserer M; Lülf A; Marr L; Jany S; Deeg CA; Pijlman GP; Koraka P; Osterhaus AD; Martina BE; Sutter G
Vaccine; 2016 Apr; 34(16):1915-26. PubMed ID: 26939903
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections.
Holmes DA; Purdy DE; Chao DY; Noga AJ; Chang GJ
J Clin Microbiol; 2005 Jul; 43(7):3227-36. PubMed ID: 16000440
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of West Nile and St. Louis encephalitis virus infections by use of noninfectious virus-like particles with reduced cross-reactivity.
Roberson JA; Crill WD; Chang GJ
J Clin Microbiol; 2007 Oct; 45(10):3167-74. PubMed ID: 17715375
[TBL] [Abstract][Full Text] [Related]
15. A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.
Bonafé N; Rininger JA; Chubet RG; Foellmer HG; Fader S; Anderson JF; Bushmich SL; Anthony K; Ledizet M; Fikrig E; Koski RA; Kaplan P
Vaccine; 2009 Jan; 27(2):213-22. PubMed ID: 18996430
[TBL] [Abstract][Full Text] [Related]
16. A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines.
Hughes HR; Crill WD; Davis BS; Chang GJ
Virology; 2012 Mar; 424(2):129-37. PubMed ID: 22244913
[TBL] [Abstract][Full Text] [Related]
17. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
[TBL] [Abstract][Full Text] [Related]
18. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
[TBL] [Abstract][Full Text] [Related]
19. Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge.
Karaca K; Bowen R; Austgen LE; Teehee M; Siger L; Grosenbaugh D; Loosemore L; Audonnet JC; Nordgren R; Minke JM
Vaccine; 2005 May; 23(29):3808-13. PubMed ID: 15893618
[TBL] [Abstract][Full Text] [Related]
20. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P
J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]